{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:47:21Z","timestamp":1793756841335,"version":"4.6.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ijantimicag.2014.06.011","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T21:46:55Z","timestamp":1406584015000},"page":"327-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-3409","authenticated-orcid":false,"given":"Felipe","family":"K. Hurtado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Victor","family":"Laureano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziela","family":"de A. Lock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4016-1370","authenticated-orcid":false,"given":"Hartmut","family":"Derendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Dalla Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jac\/46.2.157","article-title":"Chronic prostatitis\u2014an infectious disease?","volume":"46","author":"Naber","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1464-410X.2008.07495.x","article-title":"Management of bacterial prostatitis: what's new?","volume":"101","author":"Naber","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0015","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Lipsky","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijantimicag.2008.09.009","article-title":"Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissue","volume":"33","author":"Perletti","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijantimicag.2007.08.025","article-title":"Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400mg to healthy volunteers","volume":"31","author":"Wagenlehner","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0030","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/AAC.01884-13","article-title":"Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis","volume":"58","author":"Hurtado","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1439-0272.2003.tb00868.x","article-title":"Antibiotic therapy\u2014rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue","volume":"35","author":"Naber","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.45.1.293-297.2001","article-title":"Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers","volume":"45","author":"Naber","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0045","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/AAC.00733-09","article-title":"Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model","volume":"54","author":"Brillault","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0050","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1128\/AAC.01253-08","article-title":"P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model","volume":"53","author":"Brillault","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-409X(00)00107-1","article-title":"Methodological issues in microdialysis sampling for pharmacokinetic studies","volume":"45","author":"de Lange","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/43.suppl_2.69","article-title":"Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species","volume":"43","author":"Siefert","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2013.24","article-title":"Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose","volume":"2","author":"Keizer","year":"2013","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0169-2607(98)00098-4","article-title":"A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models","volume":"59","author":"Parke","year":"1999","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1023\/A:1018871029244","article-title":"Distribution characteristics of levofloxacin and grepafloxacin in rat kidney","volume":"16","author":"Ito","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jac\/dki284","article-title":"Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis","volume":"56","author":"Zeitlinger","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0085","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","article-title":"Penetration of moxifloxacin into peripheral compartments in humans","volume":"43","author":"Muller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0090","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/jnci\/92.23.1934","article-title":"Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells","volume":"92","author":"Lee","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0095","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/AAC.01428-08","article-title":"Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells","volume":"53","author":"Marquez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0100","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/38.9.1974900","article-title":"Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues","volume":"38","author":"Cordon-Cardo","year":"1990","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0105","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2014"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0110","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/cid\/cir709","article-title":"Chronic bacterial prostatitis: enterococcal disease?","volume":"53","author":"Magri","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.06.011_bib0115","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/cid\/cir715","article-title":"Chronic bacterial prostatitis: enterococcal disease? Reply to Magri et al.","volume":"53","author":"Lipsky","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914002064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914002064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T04:26:44Z","timestamp":1565670404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914002064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0924857914002064"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.06.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}